Tumor Development Under Combination Treatments with Anti-angiogenic Therapies

Optimal control of the Lotka-Volterra system: turnpike property and numerical simulations

The Lotka-Volterra model is a differential system of two coupled equations representing the interaction of two species: a prey one and a predator one. We formulate an optimal control problem adding the effect of hunting both species as the control variable. We analyse the optimal hunting problem paying special attention to the nature of the optimal state and control trajectories in long time intervals. To do that, we apply recent theoretical results on the frame to show that, when the time horizon is large enough, optimal strategies are nearly steady-state. Such path is known as turnpike property. Some experiments are performed to observe such turnpike phenomenon in the hunting problem. Based on the turnpike property, we implement a variant of the single shooting method to solve the previous optimisation problem, taking the middle of the time interval as starting point.

Modeling of Optimal Targeted Therapies Using Drug-Loaded Magnetic Nanoparticles for Liver Cancer

To enhance locoregional therapies for liver cancer treatment, we propose in this study a mathematical model to optimize the transcatheter arterial delivery of therapeutical agents. To maximize the effect of the treatment and minimize adverse effects on the patient, different mathematical models of the tumor growth are considered in this study to find the optimal number of the therapeutic drug-loaded magnetic nanoparticles to be administered. Three types of therapy models are considered, e.g., angiogenesis inhibition therapy, chemotherapy and radiotherapy. We use state-dependent Riccati equations (SDRE) as an optimal control methodology framework to the Hahnfeldt's tumor growth formulation. Based on this, design optimal rules are derived for each therapy to reduce the growth of a tumor through the administration of appropriate dose of antiangiogenic, radio- and chemo-therapeutic agents. Simulation results demonstrate the validity of the proposed optimal delivery approach, leading to reduced intervention time, low drug administration rates and optimal targeted delivery.